Evotec SE (EVO)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.00
-4.46%
Mkt Cap $1.08B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 8, 2026 | $328.78M | $346.85M | +5.50% | $0.21 | $0.05 | -73.93% | — | — |
| Q4 2025 Nov 5, 2025 | $239.92M | $191.95M | -19.99% | -$0.14 | -$0.14 | -1.44% | — | — |
| Q3 2025 Aug 13, 2025 | $191.79M | $201.62M | +5.12% | -$0.18 | -$0.14 | +19.93% | — | — |
| Q2 2025 May 6, 2025 | $275.89M | $219.23M | -20.54% | -$0.11 | -$0.19 | -77.26% | — | — |
| Q2 2025 Apr 17, 2025 | $205.30M | $229.08M | +11.58% | $0.02 | -$0.12 | -768.15% | — | — |
| Q4 2024 Nov 6, 2024 | $221.08M | $202.77M | -8.28% | -$0.08 | -$0.12 | -50.00% | — | — |
| Q3 2024 Aug 14, 2024 | $221.46M | $195.83M | -11.58% | -$0.09 | -$0.29 | -222.22% | — | — |
| Q2 2024 May 22, 2024 | $224.32M | $224.23M | -0.04% | -$0.03 | -$0.05 | -49.52% | — | — |
| Q1 2024 Feb 26, 2024 | — | $221.40M | — | -$0.03 | -$0.05 | -66.67% | — | — |
| Q4 2023 Nov 8, 2023 | $204.06M | $207.04M | +1.46% | -$0.05 | -$0.12 | -140.00% | — | — |
| Q3 2023 Aug 29, 2023 | $214.84M | $185.76M | -13.54% | -$0.04 | -$0.04 | -10.93% | — | — |
| Q2 2023 May 12, 2023 | — | $232.18M | — | $0.10 | -$0.08 | -180.00% | — | — |
| Q1 2023 Mar 29, 2023 | $236.50M | $259.26M | +9.63% | $0.10 | -$0.13 | -230.00% | — | — |
| Q4 2022 Nov 9, 2022 | $182.39M | $169.81M | -6.89% | $0.08 | -$0.26 | -419.52% | — | — |
| Q3 2022 Aug 11, 2022 | $177.63M | $180.13M | +1.40% | -$0.02 | -$0.08 | -375.06% | — | — |
| Q2 2022 May 11, 2022 | $171.19M | $182.15M | +6.40% | $0.06 | -$0.23 | -483.33% | — | — |
| Q2 2022 Apr 12, 2022 | $187.44M | $212.08M | +13.15% | $0.07 | -$0.11 | -257.14% | — | — |
| Q4 2021 Nov 11, 2021 | $209.74M | $185.32M | -11.64% | — | $0.95 | — | — | — |
| Q3 2021 Aug 11, 2021 | — | $163.99M | — | — | $0.43 | — | — | — |
| Q2 2021 May 11, 2021 | — | $156.53M | — | — | $0.38 | — | — | — |